Armata Pharmaceuticals (ARMP) Research & Development (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Research & Development of $6.1 million for Q1 2026, up 12.56% on a YoY basis from $5.4 million in Q1 2025, and up 0.68% sequentially from $6.1 million in Q4 2025.
Armata Pharmaceuticals (ARMP) Research & Development (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 14 years of Research & Development data on file, last reported at $6.1 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 12.56% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $24.4 million (down 23.37% YoY), and the FY2025 full-year result was $23.7 million, down 31.11% from the prior year.
- Research & Development advanced to $6.1 million in Q1 2026, from $6.1 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $9.6 million in Q1 2023 to a low of $5.4 million in Q1 2025.
- A 5-year average of $7.8 million and a median of $8.0 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development jumped 98.77% in 2022 and plunged 38.6% in 2025, its largest moves.
- Tracing ARMP's Research & Development over 5 years: stood at $9.6 million in 2022, then decreased by 17.15% to $7.9 million in 2023, then rose by 6.6% to $8.5 million in 2024, then slipped by 28.17% to $6.1 million in 2025, then rose by 0.68% to $6.1 million in 2026.
- Business Quant data shows ARMP's Research & Development at $6.1 million in Q1 2026, $6.1 million in Q4 2025, and $5.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | 6.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.11 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Sep 30, 2025 | 5.82 Mn |
| Jun 30, 2025 | 6.39 Mn |
| Mar 31, 2025 | 5.43 Mn |
| Dec 31, 2024 | 8.45 Mn |
| Sep 30, 2024 | 9.49 Mn |
| Jun 30, 2024 | 8.48 Mn |
| Mar 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 7.93 Mn |
| Sep 30, 2023 | 7.98 Mn |
| Jun 30, 2023 | 8.26 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 9.57 Mn |
| Sep 30, 2022 | 8.40 Mn |
| Jun 30, 2022 | 9.02 Mn |
| Mar 31, 2022 | 8.03 Mn |
| Dec 31, 2021 | 4.81 Mn |
| Sep 30, 2021 | 5.63 Mn |
| Jun 30, 2021 | 5.23 Mn |